Livingstone R, Boyle JG, Petrie JR. How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with type 1 …
Cardiovascular
-
Diabetes Complications
-
Type 2
Influence of impaired glucose tolerance and type 2 diabetes on the multimorbidity cluster of cardiovascular disease and cancer: a post hoc analysis of the Da Qing Diabetes Prevention Outcome Study | BMC Medicine
by Jinping Wangby Jinping WangSmith SM, Soubhi H, Fortin M, Hudon C, O’Dowd T. Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ. 2012;345:e5205–e5205. Article PubMed PubMed Central …
-
Healthy Living
Cardiovascular Health: Live Longer with a Heart-Healthy Lifestyle
by News Sourceby News SourceCardiovascular Health: Longevity through Heart-Healthy Living | NHLBI, NIH Skip to main content
-
Type 2
Cost of cardiovascular disease events in patients with and without type 2 diabetes and factors influencing cost: a retrospective cohort study | BMC Public Health
World Health Organization Factsheet. Cardiovascular diseases (CVDs). Published 11 June 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 31 August 2023. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, …
-
Diet
Mediterranean and DASH diets may reduce cardiovascular disease risk in adults with type 1 diabetes
by News Sourceby News SourceEating habits aligned with the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diet may help lower the risk of cardiovascular disease in adults with type 1 diabetes, …
-
Diabetes Complications
NextGen Precision Health Researchers Discover Potential Treatment for Cardiovascular Complications from Type 2 Diabetes
by News Sourceby News SourceNew research at the Roy Blount NextGen Precision Health Building has uncovered a potential treatment for the underlying cause of cardiovascular disease in people with type 2 diabetes. More than …
-
Type 2
The real-world effect of early insulin therapy on cardiovascular event rates in newly diagnosed type 2 diabetes mellitus
Information source Our data source was a nationwide collaborative network that collected electronic health records of hospitalizations and outpatient care from 19 tertiary-level comprehensive medical centers across China between January …
-
Type 2
Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure | Cardiovascular Diabetes
Study setting and patients In this double-blind, randomized trial, adult patients with type 2 diabetes received placebo or dapagliflozin 10 mg once daily for 12 months. The study began on …
-
The authors of a new review paper said that the management of cardiovascular disease is an often overlooked but important aspect of the care of patients with type 1 diabetes. …
-
Type 1
The double burden: type 1 diabetes and heart failure—a comprehensive review | Cardiovascular Diabetology
Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3:7. Article PubMed PubMed Central Google Scholar Mosterd A, Hoes AW. Clinical epidemiology of heart failure. …